158 related articles for article (PubMed ID: 27006085)
1. The Effect of rhCygb on CCl4-Induced Hepatic Fibrogenesis in Rat.
Li Z; Wei W; Chen B; Cai G; Li X; Wang P; Tang J; Dong W
Sci Rep; 2016 Mar; 6():23508. PubMed ID: 27006085
[TBL] [Abstract][Full Text] [Related]
2. Endogenous hydrogen sulfide is associated with angiotensin II type 1 receptor in a rat model of carbon tetrachloride-induced hepatic fibrosis.
Fan HN; Chen NW; Shen WL; Zhao XY; Zhang J
Mol Med Rep; 2015 Sep; 12(3):3351-3358. PubMed ID: 26034979
[TBL] [Abstract][Full Text] [Related]
3. Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2.
Zakaria S; El-Sisi A
J Immunotoxicol; 2016 Jul; 13(4):453-62. PubMed ID: 26849241
[TBL] [Abstract][Full Text] [Related]
4. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.
Wei YH; Jun L; Qiang CJ
Dig Dis Sci; 2004 Oct; 49(10):1589-94. PubMed ID: 15573910
[TBL] [Abstract][Full Text] [Related]
5. Hepatoprotective Effects of Grape Seed Procyanidin B2 in Rats With Carbon Tetrachloride-induced Hepatic Fibrosis.
Wang Z; Zhang Z; Du N; Wang K; Li L
Altern Ther Health Med; 2015; 21 Suppl 2():12-21. PubMed ID: 26308756
[TBL] [Abstract][Full Text] [Related]
6. Hepatoprotection by freshwater clam extract against CCl4-induced hepatic damage in rats.
Hsu CL; Hsu CC; Yen GC
Am J Chin Med; 2010; 38(5):881-94. PubMed ID: 20821820
[TBL] [Abstract][Full Text] [Related]
7. [Protective effect of Tanreqing injection on acute hepatic injury induced by CCl4 in rats].
Lei Y; Zhou AM; Guo T; Tan Y; Tao YY; Liu CH
Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1226-30. PubMed ID: 23944040
[TBL] [Abstract][Full Text] [Related]
8. Post-treatment of melatonin with CCl
Mortezaee K; Majidpoor J; Daneshi E; Abouzaripour M; Abdi M
J Cell Biochem; 2018 Feb; 119(2):1716-1725. PubMed ID: 28782839
[TBL] [Abstract][Full Text] [Related]
9. The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis.
Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Calatroni A
Chem Biol Interact; 2004 Jul; 148(3):125-38. PubMed ID: 15276869
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of recombinant human cytoglobin against chronic alcohol-induced liver disease in vivo and in vitro.
Wen J; Wu Y; Wei W; Li Z; Wang P; Zhu S; Dong W
Sci Rep; 2017 Jan; 7():41647. PubMed ID: 28128325
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
[TBL] [Abstract][Full Text] [Related]
12. Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats.
Tsai JH; Liu JY; Wu TT; Ho PC; Huang CY; Shyu JC; Hsieh YS; Tsai CC; Liu YC
J Viral Hepat; 2008 Jul; 15(7):508-14. PubMed ID: 18397225
[TBL] [Abstract][Full Text] [Related]
13. Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway.
Guo C; Xu L; He Q; Liang T; Duan X; Li R
Food Chem Toxicol; 2013 Jun; 56():436-42. PubMed ID: 23500774
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
Yao HW; Li J; Chen JQ; Xu SY
Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
[TBL] [Abstract][Full Text] [Related]
15. Study on the effects of blueberry treatment on histone acetylation modification of CCl
Zhan W; Liao X; Tian T; Yu L; Liu X; Li B; Liu J; Han B; Xie RJ; Ji QH; Yang Q
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218781
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of morin against liver fibrosis in rats: modulation of oxidative stress, cytokine production and nuclear factor kappa B.
Heeba GH; Mahmoud ME
Environ Toxicol Pharmacol; 2014 Mar; 37(2):662-71. PubMed ID: 24583409
[TBL] [Abstract][Full Text] [Related]
17. Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors.
Zhang BJ; Xu D; Guo Y; Ping J; Chen LB; Wang H
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):303-9. PubMed ID: 17973934
[TBL] [Abstract][Full Text] [Related]
18. [Effect of shuganjianpifang on the expression of BCL-2 and BAX in rats livers with hepatic fibrosis].
Jiang H; Gao JR; Chen JF; Ji WB
Zhong Yao Cai; 2013 May; 36(5):776-80. PubMed ID: 24218972
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of gallic acid on CCl4-mediated liver fibrosis in mice.
Wang J; Tang L; White J; Fang J
Cell Biochem Biophys; 2014 May; 69(1):21-6. PubMed ID: 24096707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]